Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$4.89 - $12.27 $2,513 - $6,306
-514 Reduced 1.06%
47,792 $234,000
Q4 2022

Feb 13, 2023

BUY
$8.88 - $12.77 $63,820 - $91,777
7,187 Added 17.48%
48,306 $519,000
Q3 2022

Nov 14, 2022

BUY
$8.24 - $12.56 $20,806 - $31,714
2,525 Added 6.54%
41,119 $385,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $13.84 $18,610 - $34,572
2,498 Added 6.92%
38,594 $352,000
Q1 2022

May 12, 2022

BUY
$9.94 - $12.65 $41,509 - $52,826
4,176 Added 13.08%
36,096 $439,000
Q4 2021

Feb 11, 2022

BUY
$11.99 - $18.14 $215 - $326
18 Added 0.06%
31,920 $389,000
Q3 2021

Nov 10, 2021

SELL
$11.55 - $16.06 $13,063 - $18,163
-1,131 Reduced 3.42%
31,902 $493,000
Q2 2021

Aug 12, 2021

BUY
$12.38 - $29.19 $408,948 - $964,233
33,033 New
33,033 $471,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $262M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.